-
Liver-focused Ambys launches with $140M, Takeda partnership
fiercebiotech
August 09, 2018
Third Rock Ventures is debuting Ambys Medicines, which will develop cell and gene therapies as well as drugs for chronic liver diseases. Ambys starts life with $140 million in committed capital, including $100 million from Takeda, part of which came in th
-
SQZ raises $72M as cell therapies close in on clinical trials
fiercebiotech
August 09, 2018
SQZ Biotechnologies has raised $72 million. The series C round sets the Roche-partnered MIT spinout to advance cell therapy treatments of solid tumors and autoimmune diseases toward the clinic.
-
Measles Case Reported in Minnesota
drugs
August 09, 2018
A Somali-American child in Minnesota has been diagnosed with the measles after returning from a trip to Africa, state health officials said Tuesday, adding that the unidentified 5-year-old in Hennepin County was not vaccinated, the Minneapolis Star Tribun
-
Quick-fire fundraisings give Apexigen $73M for I-O push
fiercebiotech
August 09, 2018
California biotech Apexigen has raised $73 million from a pair of financings that will be used for clinical testing of its lead CD40-targeting immuno-oncology candidate as well as to broaden its pipeline.
-
FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma
drugs
August 09, 2018
Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma.
-
Regenxbio’s wet AMD gene therapy shows promise in phase 1
fiercebiotech
August 09, 2018
Regenxbio reported promising interim data from a phase 1 trial of its gene therapy for wet age-related macular degeneration (AMD). The treatment.....
-
Boxers vs. Briefs and Your Chances of Becoming a Dad
drugs
August 09, 2018
Attention guys: Your tighty whities may not be doing your sperm any favors.
-
FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and Sézary Syndrome
drugs
August 09, 2018
The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior syste
-
How virus 'clusters' cause norovirus and other stomach bugs to spread
fiercebiotech
August 09, 2018
Scientists had long believed that viruses act independently to infect cells, until 2015, when a team led by researchers at the National Institute of Health illustrated that enteroviruses such as poliovirus can travel collectively in packets.
-
Novo Nordisk sees revenues drop in Q2
pharmatimes
August 09, 2018
Novo Nordisk saw revenues drop 4% in the second quarter as the diabetes segment stumbled, but reported solid performance for some of its key brands.